1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [4ba53f77-77e1-4acc-9f55-a5f59316c102] => Array ( [runtime-id] => 4ba53f77-77e1-4acc-9f55-a5f59316c102 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [387f1a1e-39cd-4367-b02a-775f1501fb91] => Array ( [runtime-id] => 387f1a1e-39cd-4367-b02a-775f1501fb91 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;20ee28030cb9bcc6d16696cb429de72fee8b1681 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => FreeToRead [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [d4fb10f0-1d91-4f82-934b-55fd18be7d0f] => Array ( [runtime-id] => d4fb10f0-1d91-4f82-934b-55fd18be7d0f [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => FreeToRead [privilege] => Array ( [776a2a55-1430-42cc-9d0d-9a94b103b7ed] => Array ( [runtime-id] => 776a2a55-1430-42cc-9d0d-9a94b103b7ed [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;20ee28030cb9bcc6d16696cb429de72fee8b1681 ) ) ) PT - JOURNAL ARTICLE AU - Sämann, P.G. AU - Knop, M. AU - Golgor, E. AU - Messler, S. AU - Czisch, M. AU - Weber, F. TI - Brain Volume and Diffusion Markers as Predictors of Disability and Short-Term Disease Evolution in Multiple Sclerosis AID - 10.3174/ajnr.A2972 DP - 2012 Aug 01 TA - American Journal of Neuroradiology PG - 1356--1362 VI - 33 IP - 7 4099 - http://www.ajnr.org/content/33/7/1356.short 4100 - http://www.ajnr.org/content/33/7/1356.full SO - Am. J. Neuroradiol.2012 Aug 01; 33 AB - BACKGROUND AND PURPOSE: MRI markers of neuroaxonal damage in MS have emerged as critical long-term predictors of MS-related disability. Here we investigated the potential of whole-brain diffusivity and brain volume for the prediction of cross-sectional disability and short- to medium-term clinical evolution. MATERIALS AND METHODS: In this multimodal prospective longitudinal MRI study of 54 patients with MS (87% under immunomodulatory therapy, baseline and follow-up at a median of 12 months), ADC histogram analysis, WM lesion load, BPF, whole-brain atrophy rate, MSFC score, and EDSS score were obtained. A total of 44 patients with no relapse at both time points were included. RESULTS: At both time points, ADC histogram analysis provided robust predictors of the MSFC scores (maximal R2 = 0.576, P < .001), incorporated cognition and fine-motor skill subscores, and EDSS scores. Significant changes beyond physiologic age-related changes at follow-up were noted for ADC histogram markers and BPF. Stronger diffusivity alterations and brain volume at baseline predicted MSFC decline, as demonstrated by multiple linear regression analysis (mean ADC, R2 = 0.203; P = .003) and lower baseline BPF in patients with declined compared with stable MSFC scores (P = .001). Results were independent of intercurrent relapses. CONCLUSIONS: Diffusion histogram analysis provided stable surrogates of disability in MS and proved sensitive for monitoring disease progression during a median of 12 months. Advanced neuroaxonal pathology at baseline was indicative of an increased risk for sustained progression during a median of 12 months, independent of intercurrent relapses. BPFbrain parenchyma fractionCIconfidence intervalEDSSExpanded Disability Status ScaleGMgray matterMSFCMS Functional Composite9-HPT9-Hole Peg TestPASATPaced Auditory Serial Addition TestPBVCpercentage brain volume changeTWTtimed walk testWMLLpercWM lesion load volume as percentage of total WM volume